Organisation paid for research Program year 2025 Source: CMS Open Payments

Alsa Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$108,461

9 payments

Through program year 2025, Alsa Research, LLC is reported as receiving $108,461 in research payments, across 9 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$61,562	4
2024	Research	$4,435	1
2023	Research	$3,206	2
2021	Research	$39,259	2

Breakdown

Who paid Research payments · program years 2021–2025

AstraZeneca Pharmaceuticals LP $58,412 3 payments
AstraZeneca UK Limited $42,464 4 payments
E.R. Squibb & Sons, L.L.C. $7,585 2 payments

Studies the money was for Research payments · program years 2021–2025

a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older $47,412 2 payments
A Phase 2 Multinational Randomized Double blind Parallel group 16 week Placebo controlled Study with a 36 week Extension to Investigate the Use of Benralizumab for Patients with Moderate to Severe Atopic Dermatitis Despite Treatment with Topical Medications $42,464 4 payments
a phase third,randomised,double blind,placebo controlled,eventdriven study to evaluate the effect of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on the risk of incident heart failure and cardiovascular death in participants with increased risk of reveloping heart failure $11,000 1 payment
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis (POETYK PSO-LTE) $7,585 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.